SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Effect Of Regulation On Pharmaceutical Revenues: Experience In Nineteen Countries
8 references·0 citing·38 second hop
The Effect Of Regulation On Pharmaceutical Revenues: Experience In Nineteen Countries (2008)The Effect Of Regulation On Pharmaceutica…The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s (2004)The impact of price regulatio…Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand (2004)Reference Pricing of Pharmace…Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry (2004)Market Size in Innovation: Th…Pharmaceutical Pricing in a Regulated Market (2003)Pharmaceutical Pricing in a R…The pharmaceutical industry as a medicines provider (2002)The pharmaceutical industry a…Do Pharmaceutical Prices Respond to Potential Patient Out-of-Pocket Expenses? (2002)Do Pharmaceutical Prices Resp…The Link Between Gross Profitability And Pharmaceutical R&D Spending (2001)The Link Between Gross Profit…Does Regulation Drive Out Competition in Pharmaceutical Markets? (2000)Does Regulation Drive Out Com…Another look at the instrumental variable estimation of error-components models (1995)Initial conditions and moment restrictions in dynamic panel data models (1998)Econometric Analysis of Cross Section and Panel Data (2001)Fifty Years of Empirical Studies of Innovative Activity and Performance (2010)The productivity crisis in pharmaceutical R&D (2011)Why Working from Home Will Stick (2021)The Determinants of Industrial Research and Development: A Study of the Chemical, Drug, and Petroleum Industries (1968)Demand-Pull and Technological Invention: Schmookler Revisted (1982)R & D and Internal Finance: A Panel Study of Small Firms in High-Tech Industries (1994)Pharmaceuticals in U.S. Health Care: Determinants of Quantity and Price (2002)Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation? (2008)Economics of the Pharmaceutical Industry (2018)Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Generic Entry and the Pricing of Pharmaceuticals (1997)Sales Growth of New Pharmaceuticals Across the Globe: The Role of Regulatory Regimes (2009)Cost of innovation in the pharmaceutical industry (1991)Prices And Availability Of Pharmaceuticals: Evidence From Nine Countries (2003)Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States (2014)Federal Republic of Germany (1985)Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)Free for All? Lessons from the RAND Health Insurance Experiment (1995)Reference pricing of pharmaceuticals (2006)What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries (2008)Impact of European Pharmaceutical Price Regulation on Generic Price Competition (2010)Success rates for new drugs entering clinical testing in the United States (1995)Access to Essential Drugs in Poor Countries (1999)GLOBAL TRADE AND PUBLIC HEALTH (2005)Prices & availability of common medicines at six sites in India using a standard methodology. (2007)Does the Market Share of Generic Medicines Influence the Price Level? (2011)An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments (1973)Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents (2003)Pharmaceutical Price Controls and Entry Strategies (2007)Market size and pharmaceutical innovation (2015)Medical insurance: A case study of the tradeoff between risk spreading and appropriate incentives (1970)Cross-national price differences for pharmaceuticals: how large, and why? (2000)Effects of Reference Pricing in Pharmaceutical Markets (2010)Pharmaceutical Prices under Regulation: Tiered Co-payments and Reference Pricing in Germany (2012)
this work references cited by second hop

References

  • 2004Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry971 cited
  • 2004The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s344 cited
  • 2000Does Regulation Drive Out Competition in Pharmaceutical Markets?237 cited
  • 2001The Link Between Gross Profitability And Pharmaceutical R&D Spending183 cited
  • 2002The pharmaceutical industry as a medicines provider165 cited
  • 2002Do Pharmaceutical Prices Respond to Potential Patient Out-of-Pocket Expenses?150 cited
  • 2004Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand126 cited
  • 2003Pharmaceutical Pricing in a Regulated Market99 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work